Abstract
Objective
The performance of microPET using18F-FDG was evaluated in a rabbit model of hematogenous pulmonary metastatic cancer.
Methods
A total of 15 Japanese white rabbits and VX-2 carcinoma were used in this study. In the microPET study, tumor-bearing rabbits were administered intravenously 74 MBq of18F-FDG, and 30 min later, the emission data were acquired for 60 min. The transmission scans were performed with a68Ge/68Ga external point source. To augment the anatomical information, we performed multi-detector row computed tomography (MDCT) in the combination with MDCT and microPET on 10 rabbits. The other 5 rabbits were followed once a week for 5 weeks only by microPET. Tumor/muscle (T/M) ratios were used for quantitative evaluation in this study.
Results
Multiple pulmonary nodules were detected by MDCT and microPET starting 14 days after the tumor injection. The high-uptake lesions in the lung detected by microPET corresponded well to the tumors detected by MDCT. The smallest nodule detected by microPET was ca. 1.5 mm in diameter. Overall, 87 nodules were detected by MDCT and the ratios of lesions detected by microPET to those by MDCT were 35.3%, 77.5%, and 90% for tumors equal to or smaller than 2 mm, 2-4 mm, and 4-6 mm in diameter, respectively. The respective T/M ratios were 2.41 ±0.41, 2.93 ± 0.55, and 3.34 ±0.71. The T/M ratio increased with tumor size, but it was similar in each tumor size category. In the 35-day follow-up protocol, it was possible to follow sequentially the same tumor by the microPET.
Conclusions
By FDG-microPET, it is possible to evaluate tumors larger than 2 mm in diameter and to follow the growth of individual tumors. Our results also suggest that the rabbit model of VX-2 pulmonary metastasis is a stable experimental model for evaluation using FDG. Monitoring of the therapeutic effects of anticancer drugs and radiation therapy could be tried by using this model and microPET.
Similar content being viewed by others
References
Kubota K, Matsuzawa T, Fujiwara T, Ito M, Hatazawa J, Ishiwata K, et al. Differential diagnosis of lung tumor with positron emission tomography: a prospective study.J Nucl Med 1990; 31: 1927–1932.
Di Chiro G. Positron emission tomography using [15F] fluorodeoxyglucose in brain tumors: a powerful diagnostic and prognostic tool.Invest Radiol 1987; 22: 360–371.
Slosman DO, Spiliopoulos A, Couson F, Nicod L, Louis O, Lemoine R, et al. Satellite PET and lung cancer: a prospective study in surgical patients.Nucl Med Commun 1993; 14: 955–961.
Hubner KF, Buonocore E, Singh SK, Gould HR, Cotton DW. Characterization of chest masses by FDG positron emission tomography.Clin Nucl Med 1995; 20: 293–298.
Gupta NC, Maloof J, Gunel E. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET.J Nucl Med 1996; 37: 943–948.
Dewan NA, Shehan CJ, Reeb SD, Gobar LS, Scott WJ, Ryschon K, et al. Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan.Chest 1997; 112: 416–422.
Demura Y, Tsuchida T, Ishizaki T, Mizuno S, Totani Y, Ameshima S, et al.18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax.J Nucl Med 2003; 44: 540–548.
Yonekura Y, Benua RS, Brill AB, Som P, Yeh SD, Kemeny NE, et al. Increased accumulation of 2-deoxy-2-18F-2-fluoro-d-glucose in liver metastases from colon carcinoma.J Nucl Med 1982; 23: 1133–1137.
Messa C, Choi Y, Hoh CK, Jacobs EL, Glaspy JA, Rege S, et al. Quantification of glucose utilization in liver metastases: parametric imaging of FDG uptake with PET.J Comput Assist Tomogr 1992; 16: 684–689.
Strauss LG, Clorius JH, Schlag P, Lehner B, Kimmig B, Engenhart R, et al. Recurrence of colorectal tumors: PET evaluation.Radiology 1989; 170: 329–332.
Okazumi S, Isono K, Enomoto K, Kikuchi T, Ozaki M, Yamamoto H, et al. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment.J Nucl Med 1992; 33: 333–339.
Som P, Atkins HL, Bandoypadhyay D, Fowler JS, MacGregor RR, Matsui K, et al. A fluorinated glucose analog, 2-fluoro-2-deoxy-d-glucose (18F): nontoxic tracer for rapid tumor detection.J Nucl Med 1980; 21: 670–675.
Fukuda H, Matsuzawa T, Abe Y, Endo Y, Kubota K, Hatazawa J, et al. Experimental study for cancer diagnosis with positron-labeled fluorinated glucose analogs:18F-2-fluoro-deoxy-d-mannose: a new tracer for cancer detection.Eur J Nucl Med 1982; 7: 294–297.
Fukuda H, Yoshioka S, Watanuki S, Kiyosawa M, Sato T, Matsuzawa T, et al. Experimental study for cancer diagnosis with18FDG: differential diagnosis of inflammation from malignant tumor.KAKU IGAKU (Jpn J Nucl Med) 1983; 20: 1189–1192.
Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Autoradiographic demonstration of [18F]FDG distribution within mouse FM3A tumor tissuein vivo.KAKU IGAKU (Jpn J Nucl Med) 1992; 29: 1215–1221.
Ishimori T, Saga T, Mamede M, Kobayashi H, Higashi T, Nakamoto Y, et al. Increased18F-FDG uptake in a model of inflammation: Concanavalin A-mediated lymphocyte activation.J Nucl Med 2001; 43: 658–663.
Cherry SR, Shao Y, Silverman RW, Meador K, Siegel S, Chatziioannou A, et al. MicroPET: a high resolution PET scanner for imaging small animals.IEEE Trans Nucl Sci 1997; 44: 1161–1166.
Chatziioannou AF, Cherry SR, Shao Y, Silverman RW, Meadors K, Farquhar TH, et al. Performance evaluation of microPET: a high-resolution lutetium oxyorthosilicate PET scanner for animal imaging.J Nucl Med 1999; 40: 1164–1175.
Tai YC, Chatziioannou A, Siegel S, Young J, Newport D, Goble RN, et al. Performance evaluation of microPET P4: a PET system dedicated to animal imaging.Phys Med Biol 2001; 46: 1845–1862.
Moore A, Osteen CL, Chatziioannou AF, Hovda DA, Cherry SR. Quantitative assessment of longitudinal metabolic changesin vivo after traumatic brain injury in the adult rat using FDG-microPET.J Cereb Blood Flow Metab 2000; 20: 1492–1501.
Komblum HI, Araujo DM, Annala AJ, Tatsukawa KJ, Phelps ME, Cherry SR.In vivo imaging of neuronal activation and plasticity in the rat brain by high resolution positron emission tomography (microPET).Nature Biotech 2000; 18: 655–660.
Matsumura A, Mizokawa S, Tanaka M, Wada Y, Nozaki S, Nakamura F, et al. Assessment of microPET performance in analyzing the rat brain under different type of anesthesia: Comparison between quantitative data obtained with microPET andex vivo autoradiography.Neuroimage 2003; 20: 2040–2050.
Oyama N, Kim J, Jones LA, Mercer NM, Engelbach JA, Sharp TL, et al. MicroPET assessment of androgenic control of glucose and acetate uptake in the rat prostate cancer tumor model.Nucl Med Biol 2002; 29: 783–790.
Oya N, Nagata Y, Ishigaki T, Abe M, Tamaki N, Magata Y, et al. Evaluation of experimental liver tumors using fluorine-18-2-deoxy-d-glucosePET.J Nucl Med 1993; 34: 2124–2129.
Oya N, Nagata Y, Tamaki N, Takagi T, Murata R, Magata Y, et al. FDG-PET evaluation of therapeutic effect on VX2 liver tumor.J Nucl Med 1996; 37: 296–302.
Kim WS, Im JG, Chung EC, Han MH, Han JK, Han MC, et al. Hematogenous pulmonary metastasis: an experimental study using VX-2 carcinoma in rabbits.Acta Radiologica 1993; 34: 581–585.
Kidd JG, Rous P. A transplantable rabbit carcinoma originating in a virus-induced papilloma and containing the virus in masked or altered form.J Exp Med 1940; 71: 813.
Concorde Microsystems: A primer for quantification using microPET systems. Rev. 3, microPET manuals, 2003. 29. Burgener FA. Peripheral hepatic artery embolization in rabbits with VX2 carcinomas of the liver.Cancer 1980; 46: 56–63.
Burgener FA, Gothlin JH. Angiographic, microangiographic and hemodynamic evaluation of hepatic artery embolization in the rabbit.Invest Radiol 1978; 13: 306–312.
Wolf HJ, Bitman WR, Voelkel EF, Griffiths HJ, Tashjian AH. Systemic effects of the VX2 carcinoma on the osseous skeleton. A quantitative study of trabecular bone.Lab Invest 1978; 38: 208.
Pillai KM, McKeever PE, Knutsen CA, Terrio PA, Prieskom DM, Ensminger WD. Microscopic analysis of arterial microsphere distribution in rabbit liver and hepatic VX2 tumor.Sel Cancer Ther 1991; 7: 39–48.
Hanai K, Tukagosi S, Muramatu S. Optimum techniques for helical and nonhelical CT.Gazou Shindan (Japanese Journal of Diagnostic Imaging) 2001; 21: 765–775. (in Japanese)
Vaska P, Alexoff DL. Effects of natural LSO radioactivity on microPET quantitation. [abstract]J Nucl Med 2003; 44 (Suppl): p138.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kondo, S., Hosono, M.N., Ishii, K. et al. Use of FDG-microPET for detection of small nodules in a rabbit model of pulmonary metastatic cancer. Ann Nucl Med 18, 51–57 (2004). https://doi.org/10.1007/BF02985614
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02985614